Compare HAS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAS | MEDP |
|---|---|---|
| Founded | 1923 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.9B |
| IPO Year | 1994 | 2016 |
| Metric | HAS | MEDP |
|---|---|---|
| Price | $101.29 | $440.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 12 |
| Target Price | $103.90 | ★ $496.09 |
| AVG Volume (30 Days) | ★ 2.1M | 427.5K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 15.28 |
| Revenue | ★ $5,365,900,000.00 | N/A |
| Revenue This Year | $4.76 | $13.07 |
| Revenue Next Year | $6.34 | $7.44 |
| P/E Ratio | ★ N/A | $28.67 |
| Revenue Growth | ★ 13.06 | N/A |
| 52 Week Low | $49.00 | $250.05 |
| 52 Week High | $106.98 | $628.92 |
| Indicator | HAS | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 60.50 | 30.42 |
| Support Level | $72.97 | $402.35 |
| Resistance Level | $106.98 | $470.79 |
| Average True Range (ATR) | 2.92 | 20.61 |
| MACD | -0.53 | -0.80 |
| Stochastic Oscillator | 51.54 | 32.00 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.